mHealth (mobile Health) is more and more becoming the standard when it comes to Patient Reported Outcomes (ePRO) or patient engagement in the discipline of pharmacovigilance. According to the Center for Connected Health Policy, remote patient monitoring is the use of “digital technologies to collect medical and other forms of health data from individuals in one location and electronically transmit that information securely to health care providers in a different location for assessment and recommendations.”
Capital Blue Cross conducted a study in 2016 and their research found that when heart failure patients used remote patient monitoring devices, it cut hospitalizations by nearly one-third. “Not only is chronic disease expensive, difficult to manage and a drain on our healthcare system, but it also takes a toll on patients and families, decreasing their quality of life and often leading to an accelerated transition out of the home and into facility-based care,” said Jennifer Chambers, MD, Chief Medical Officer at Capital Blue Cross.
For the full article please visit : http://patientengagementhit.com/features/how-mhealth-technology-supports-patient-engagement-strategies